Terpenoid ID | TKC103150 | |
Chirality | TKC035984 | |
Cell line | 0 | |
Protein target | 24 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 38 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC103150 | HEK293 | 3162.0 | nM | Potency |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC103150 | Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH2 | 22387 | nM | Potency |
TKC103150 | P00352 | Retinal dehydrogenase 1 | ALDH1A1 | 39811 | nM | Potency |
TKC103150 | P10636 | Microtubule-associated protein tau | MAPT | 126 | nM | Potency |
TKC103150 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 17783 | nM | Potency |
TKC103150 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 17783 | nM | Potency |
TKC103150 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 31623 | nM | Potency |
TKC103150 | Q9UNA4 | DNA polymerase iota | POLI | 19953 | nM | Potency |
TKC103150 | O75496 | Geminin | GMNN | 6310 | nM | Potency |
TKC103150 | O89049 | Thioredoxin reductase 1, cytoplasmic | Txnrd1 | 28184 | nM | Potency |
TKC103150 | P28482 | Mitogen-activated protein kinase 1 | MAPK1 | 3548 | nM | Potency |
TKC103150 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 10000 | nM | Potency |
TKC103150 | P54132 | Bloom syndrome protein | BLM | 12589 | nM | Potency |
TKC103150 | Q01453 | Peripheral myelin protein 22 | PMP22 | 60 | nM | Potency |
TKC103150 | Q6W5P4 | Neuropeptide S receptor | NPSR1 | 1259 | nM | Potency |
TKC103150 | O00255 | Menin | MEN1 | 10000 | nM | Potency |
TKC103150 | P02791 | Ferritin light chain | FTL | 12589 | nM | Potency |
TKC103150 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | HPGD | 22387 | nM | Potency |
TKC103150 | P25779 | Cruzipain | 15849 | nM | Potency | |
TKC103150 | P06746 | DNA polymerase beta | POLB | 22387 | nM | Potency |
TKC103150 | Q9Y253 | DNA polymerase eta | POLH | 17783 | nM | Potency |
TKC103150 | P02545 | Prelamin-A/C | LMNA | 50 | nM | Potency |
TKC103150 | Q194T2 | Non-structural protein 1 | NS1 | 8913 | nM | Potency |
TKC103150 | P10253 | Lysosomal alpha-glucosidase | GAA | 14125 | nM | Potency |
TKC103150 | P06280 | Alpha-galactosidase A | GLA | 14125 | nM | Potency |
TKC103150 | Q99549 | M-phase phosphoprotein 8 | MPHOSPH8 | 1000 | nM | Potency |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
Q12809 | KCNH2_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |
Q12809 | KCNH2_HUMAN | Sleep-wake disorder [ICD-11: 7A00-7B2Z] |
Q12809 | KCNH2_HUMAN | Malaria [ICD-11: 1F40-1F45] |
Q12809 | KCNH2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
Q12809 | KCNH2_HUMAN | Pain [ICD-11: MG30-MG3Z] |
Q12809 | KCNH2_HUMAN | Cardiac arrhythmia [ICD-11: BC9Z] |
Q12809 | KCNH2_HUMAN | Angina pectoris [ICD-11: BA40] |
Q12809 | KCNH2_HUMAN | Genetic cardiac arrhythmia [ICD-11: BC65] |
Q12809 | KCNH2_HUMAN | Ovarian cancer [ICD-11: 2C73] |
P10636 | TAU_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 | TAU_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P10636 | TAU_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 | TAU_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P10636 | TAU_HUMAN | Parkinsonism [ICD-11: 8A00] |
P10636 | TAU_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 | TAU_HUMAN | Neurodegenerative disorder [ICD-11: 8A20-8A23] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P28482 | MK01_HUMAN | Melanoma [ICD-11: 2C30] |
P28482 | MK01_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P28482 | MK01_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P28482 | MK01_HUMAN | Arteries/arterioles disorder [ICD-11: BD52] |
P28482 | MK01_HUMAN | Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P28482 | MK01_HUMAN | Transplant rejection [ICD-11: NE84] |
P28482 | MK01_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
P28482 | MK01_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P25779 | CYSP_TRYCR | Parasitic worm infestation [ICD-11: 1F90] |
P25779 | CYSP_TRYCR | Malaria [ICD-11: 1F40-1F45] |
P06746 | DPOLB_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10253 | LYAG_HUMAN | Inborn carbohydrate metabolism error [ICD-11: 5C51] |
P06280 | AGAL_HUMAN | Lysosomal disease [ICD-11: 5C56] |